At CRS, we are dedicated to advancing the development
of new drugs that improve patients’ lives. With over 40
years of experience, we are a trusted partner in the
healthcare industry, specializing in early phase
clinical research.
CRS is a leading full-service early phase Contract Research Organization (CRO) with three state-of-the-art research units in Germany. We excel in innovative solutions for early clinical development, from First-in-Human studies to Proof-of-Concept trials in patients.
We specialize in metabolic and cardiovascular disorders, women’s health, and clinical trials involving renal and hepatic impaired patients. Leveraging our deep knowledge, we provide expert guidance to navigate the complexities of drug development.
Our extensive expertise makes us an ideal partner for biopharmaceutical companies, offering strategic and tactical project-related outsourcing partnerships.
CRS was established in 2006 through the merger of three renowned CROs in Germany:
These organizations brought together over 40 years of collective experience in clinical pharmacology and Phase I clinical trials. Today, CRS operates three Clinical Pharmacology Units (CPUs) across Germany, with a combined capacity of more than 160 beds. This infrastructure positions us as one of Europe’s leading providers of Phase I clinical trial services, offering both standard PharmacoKinetic (PK) / PharmacoDynamic (PD) trial designs and specialized Phase I studies.
CRS was established in 2006 through the merger of three renowned CROs in Germany:
These organizations brought together over 40 years of collective experience
in clinical pharmacology and Phase I clinical trials. Today, CRS operates three
Clinical Pharmacology Units (CPUs) across Germany, with a combined
capacity of more than 160 beds. This infrastructure positions us as one of
Europe’s leading providers of Phase I clinical trial services, offering both standard PharmacoKinetic (PK) / PharmacoDynamic (PD) trial designs and
specialized Phase I studies.
Our clients span pharmaceuticals, biotech, medicinal products, nutritional, and cosmetics industries. CRS delivers a comprehensive suite of services, including early phase clinical trials in healthy volunteers, patient-driven trials, and multicenter trials.
Partner with us to benefit from our proven track record and commitment to excellence in early phase drug development strategies.